← FDA DRUG APPROVALS

FDA ANDA · ANDA207536

FLUCYTOSINE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA207536
TYPE
ANDA
ORIGINAL APPROVAL
2018-06-18
LATEST ACTION
2018-06-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FLUCYTOSINEDiscontinued
FLUCYTOSINE 250MG · CAPSULE · ORAL
FLUCYTOSINEDiscontinued
FLUCYTOSINE 500MG · CAPSULE · ORAL

Approval history

2018-06-18UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →